Clusters of circulating cells commonly found in the blood of cancer patients have long been the subject of research on cancer. These clusters have been regarded for more than 50 years as malignant cells that have broken off ...
Jul 11, 2016
0
127
Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin. It was previously believed ...
Jun 7, 2016
0
160
The research thoroughly reviews the importance of the blood-brain barrier (BBB) and the blood-tumor barrier (BTB) along with the current status and future perspectives of interesting physical and surgical strategies to circumvent ...
Mar 9, 2016
0
12
The human brain has a remarkable defense system that filters bacteria and chemicals. For brain tumor patients, the barrier works almost too well by blocking most chemotherapy drugs.
Feb 24, 2016
0
2
Cancer is a malignant force of nature that holds no prejudice when it invades tissue, permeates and forms new body sites. Ninety percent of deaths caused by cancer are due to tumors spreading throughout the body, a process ...
Dec 1, 2015
0
2
Angiosarcoma is a malignant cancer of the endothelial cells of blood or lymphatic vessels. Cutaneous angiosarcoma, a form of skin cancer, commonly occurs on the scalp of elderly people and can rapidly metastasize to the liver, ...
Nov 1, 2015
0
19
It has been treasured by food lovers for thousands of years for its rich golden colour, peppery flavour and mustardy aroma…and now turmeric may also have a role in fighting cancer.
Jul 3, 2015
0
191
(Medical Xpress)—A team of researchers with member affiliations to institutions in the U.S. and Germany has uncovered the mechanism by which a cancer fighting drug reduces cancer cells and also helps patients with a blood ...
Researchers have designed a way to mitigate graft-versus-host disease, a common and often life-threatening complication of bone marrow transplants that are used to treat leukemia and other blood cancers.
May 12, 2015
0
19
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the ...
Apr 20, 2015
0
7
